Scientific Advisory Committee

Our partners are so important and we accomplish a lot together.

Ian Tannock, MD, PhD - Co-Chair


Dr. Ian F. Tannock obtained his PhD in 1968 from the Institute of Cancer Research, London, United Kingdom and graduated Medicine in 1974 from the University of Pennsylvania, Philadelphia, United States of America. He is the Daniel E. Bergsagel Professor of Medical Oncology as well as a staff physician at the Princess Margaret Hospital and the University of Toronto, Toronto, Ontario. His laboratory-based research focuses on physiological causes of resistance to chemotherapy in solid tumours and methods of overcoming them. His clinical research interests are prostate and breast cancers, fatigue and cognitive dysfunction associated with chemotherapy. Dr. Tannock was a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) from 2001-2004. He received the alumnus award from M.D. Anderson Hospital, Houston, USA (1989), the Warwick Prize from the National Cancer Institute of Canada (2003), an honorary degree (DSc) from London University, UK (2009), and the European Society of Medical Oncology (ESMO) award (2012), the first non-European to receive this award. He chairs the scientific audit committee of the European Organisation for Research and Treatment of Cancer (EORTC) and is a member of the EORTC Board.

Dr. Tannock was appointed a Member of the Order of Canada in December 2013.

Gabriel Hortobagyi, MD - Co-Chair


Dr. Gabriel N. Hortobagyi, MD, FACP, FASCP is a Professor of Medicine, Chair Emeritus of the Department of Breast Medical Oncology and Nellie B. Connally Chair in Breast Cancer at the University of Texas M.D. Anderson Cancer Center (MDACC). He has been dedicated to breast medical oncology for more than 41 years. Dr. Hortobagyi was President of the American Society of Clinical Oncology (ASCO) from 2006 to 2007.

For his efforts in breast cancer research, he has received worldwide honors. In 2001, President Jacques Chirac named him Chevalier of the Order of la Legion d'Honneur de France. In 2003, he received the Glen Robbins Award in Breast Cancer Research from the New York Cancer Society and the Metropolitan Breast Cancer Group and the Bristol-Myers Squibb 2003 Horizon Scientific Award. The Mexican Society of Oncology named him the 2005 World Leader in Oncology. He has also received the Mario Rabinovich prize (2005), the Luigi Castagnetta prize (2006), the Cancer Care Beacon Award (2007), the Civic Cross Jorge Bejarano (2007), the Charles A. LeMaistre Outstanding Achievement Award (2009), the John Mendelsohn Lifetime Scientific Achievement Award (2009), the Jenaro Haddock prize (2011), the Bob Pinedo Award (2011), the Addarii Award (2011), the Jill Rose Award (2012), the William L. McGuire Award (2012) and the Jane Cooke Wright Award from AACR (2013). He was elected honorary member of 14 international societies and received Laurea Honoris Causa from the Universities of Modena, Monterrey and Buenos Aires. He has contributed more than 900 articles to scientific journals, authored and co-authored 13 books and contributed over 140 chapters to textbooks.